Fmr LLC Century Therapeutics, Inc. Transaction History

Fmr LLC

$1.68 Trillion
Q2 2025

A detailed history of Fmr LLC transactions in Century Therapeutics, Inc. stock. As of the latest transaction made, Fmr LLC holds 1,020,614 shares of IPSC stock, worth $581,749. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,020,614

Previous 2,594,745 60.67%

Holding current value

$581,749

Previous $1.25 Million 54.14%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	SELL	$0.39 - $0.63 $613,911 - $991,702	-1,574,131 Reduced 60.67%	1,020,614 $571,000
Q1 2025 May 12, 2025	BUY	$0.48 - $1.11 $29,218 - $67,566	60,871 Added 2.4%	2,594,745 $1.25 Million
Q4 2024 Feb 13, 2025	BUY	$1.0 - $1.72 $12,363 - $21,264	12,363 Added 0.49%	2,533,874 $2.56 Million
Q3 2024 Nov 13, 2024	SELL	$1.44 - $3.29 $617,425 - $1.41 Million	-428,768 Reduced 14.53%	2,521,511 $4.31 Million
Q2 2024 Aug 13, 2024	SELL	$2.46 - $4.05 $1.04 Million - $1.7 Million	-420,949 Reduced 12.49%	2,950,279 $7.52 Million
Q1 2024 May 13, 2024	SELL	$3.19 - $5.32 $769,820 - $1.28 Million	-241,323 Reduced 6.68%	3,371,228 $14.1 Million
Q4 2023 Feb 13, 2024	SELL	$1.28 - $3.32 $1.17 Million - $3.03 Million	-912,078 Reduced 20.16%	3,612,551 $12 Million
Q3 2023 Nov 13, 2023	SELL	$2.0 - $3.23 $1.29 Million - $2.08 Million	-643,866 Reduced 12.46%	4,524,629 $9.05 Million
Q2 2023 Aug 11, 2023	SELL	$2.91 - $3.53 $507,760 - $615,942	-174,488 Reduced 3.27%	5,168,495 $16.3 Million
Q1 2023 May 11, 2023	SELL	$3.4 - $5.11 $5.96 Million - $8.96 Million	-1,753,428 Reduced 24.71%	5,342,983 $18.5 Million
Q4 2022 Feb 13, 2023	SELL	$4.84 - $11.58 $638,347 - $1.53 Million	-131,890 Reduced 1.82%	7,096,411 $36.4 Million
Q3 2022 Nov 10, 2022	SELL	$8.57 - $13.1 $2.98 Million - $4.56 Million	-348,084 Reduced 4.59%	7,228,301 $71.5 Million
Q2 2022 Aug 12, 2022	SELL	$7.96 - $12.43 $5.2 Million - $8.12 Million	-652,906 Reduced 7.93%	7,576,385 $63.6 Million
Q1 2022 May 13, 2022	BUY	$11.62 - $15.92 $384,482 - $526,760	33,088 Added 0.4%	8,229,291 $104 Million
Q4 2021 Feb 14, 2022	BUY	$13.93 - $23.62 $496,172 - $841,320	35,619 Added 0.44%	8,196,203 $130 Million
Q3 2021 Nov 15, 2021	BUY	$20.8 - $31.93 $66.6 Million - $102 Million	3,201,173 Added 64.55%	8,160,584 $205 Million
Q2 2021 Aug 13, 2021	BUY	$22.45 - $29.34 $111 Million - $146 Million	4,959,411 New	4,959,411 $146 Million

Others Institutions Holding IPSC

# of Institutions

Shares Held

23.8M

Call Options Held

33.4K

Put Options Held

View Full List

About Century Therapeutics, Inc.

Ticker IPSC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,881,800
Market Cap $33.6M
Description
Century Therapeutics, Inc., a biotechnology company, develops transformative allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. The company's lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy targeting CD19 fo...

More about IPSC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account